Skip to content

Total at other companies

Collegium Pharmaceutical, Inc. logo
Collegium Pharmaceutical, Inc.COLL
$157.51M
BioLife Solutions logo
BioLife SolutionsBLFS
$88.79M+118%
KDK
Kodiak AI, Inc. Common StockKDK
$25.24M
Absci Corporation logo
Absci CorporationABSI
$122.78M+41.1%
Hagerty logo
HagertyHGTY
$73.56M-21.3%
GitLab logo
GitLabGTLB
$619.16M-1.8%

Other financials

Income statement

See full
Revenue$41.9M+14.3%
Gross profit$31.1M+14.5%
Operating income-$10.1M+20.0%
Net income-$9.6M+15.6%
EPS (diluted)-$0.15+21.1%

Balance sheet

See full
Cash & equivalents$17.6M-48.9%
Total debt$6.3M-28.4%
Total equity$123.9M-12.8%
Total assets$162.4M-3.4%

Cash flow

See full
Operating cash flow-$11.7M-11.3%
CapEx$700.0K+33.3%
Free cash flow-$12.4M-12.3%

Valuation

See full
Market cap$242.43M-7.6%
Enterprise value$231.1M-7.2%
P/S1.5×-0.3×

Profitability

See full
Gross margin74.9%+1.0pp
Operating margin-28.1%-7.1pp
Net margin-26.3%-6.4pp
FCF margin-12.1%

Returns & leverage

See full
Return on equity-32%-1.6pp
Debt / equity0.1×0.0×
Current ratio4.2×-3.3×

Where this comes from

Reported directly by CS Disco in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis.

The official record: CS Disco’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about CS Disco's total.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CS Disco's total?
CS Disco (LAW) reported total of $89.69M in Q1 2026.
How has CS Disco's total changed year-over-year?
CS Disco's total decreased by 2.2% year-over-year, from $91.73M to $89.69M.